Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

SAGETRACK

Sign In to gain access to subscriptions and/or personal tools.
Journal of the Society for Gynecologic Investigation
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Heffner, L. J.
Right arrow Articles by Benoit, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heffner, L. J.
Right arrow Articles by Kumari, M.
Right arrow Articles by Benoit, L. A.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Secretion of the Vasoactive Peptides, Endothelin, and Parathyroid Hormone-Related Peptide, by Decidual Explants From Pregnancies Complicated by Intrauterine Growth Restriction

Linda J. Heffner, MD, PhD

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gyneclogy, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; Division of Maternal-Fetal Medicine, ljheffner{at}bics.bwh.harvard.edu

Meena Kumari, PhD

Lynne A. Benoit, BS

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gyneclogy, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts

Objective: To determine whether in vitro secretion of two vasoactive peptides, endothelin and parathyroid hormone-related peptide (PTHrP), is different in decidua from pregnancies complicated by intrauterine growth restriction (IUGR) than in normal pregnancies.

Methods: In ten IUGR and nine gestational age-matched control pregnancies, decidua was collected at delivery and explants cultured for 24 hours. Endothelin and PTHrP concentrations in the conditioned medium were determined. Lactate dehydrogenase release into the medium was measure at 4 and 24 hours in a separate group of four IUGR and three control decidua.

Results: Endothelin and PTHrP secretion by the decidua of the IUGR pregnancies were markedly lower than those in controls (endothelin 51 ± 11 versus 105 ± 16 pg/100 mg tissue/24 hours, P = .01; PTHrP 164 ± 17 versus 641 ± 209 ng/100 mg tissue/24 hours, P = .02). Lactate dehydrogenase release into the medium was not different between the IUGR and control dedicua.

Conclusions: Based on the known effects of endothelin and PTHrP on vascular smooth muscle, it was originally anticipated that more endothelin and less PTHrP would be secreted by the IUGR decidua than the control. The finding that both peptides decreased could not be explained by route of delivery or global tissue dysfunction. Investigation of potential mediators of decidual ET and PTHrP will be necessary to determine why these hormones are both decreased in pregnancies complicated by IUGR.

Key Words: Intrauterine growth restriction (fetal growth restriction) • endothelin • parathyroid hormone-related peptide • decidua

Journal of the Society for Gynecologic Investigation, Vol. 6, No. 5, 273-277 (1999)
DOI: 10.1177/107155769900600509
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?